1. Home
  2. PLSE vs CRI Comparison

PLSE vs CRI Comparison

Compare PLSE & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • CRI
  • Stock Information
  • Founded
  • PLSE 2014
  • CRI 1865
  • Country
  • PLSE United States
  • CRI United States
  • Employees
  • PLSE N/A
  • CRI N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • CRI Apparel
  • Sector
  • PLSE Health Care
  • CRI Consumer Discretionary
  • Exchange
  • PLSE Nasdaq
  • CRI Nasdaq
  • Market Cap
  • PLSE 1.3B
  • CRI 1.5B
  • IPO Year
  • PLSE 2016
  • CRI 2003
  • Fundamental
  • Price
  • PLSE $17.74
  • CRI $36.37
  • Analyst Decision
  • PLSE
  • CRI Hold
  • Analyst Count
  • PLSE 0
  • CRI 4
  • Target Price
  • PLSE N/A
  • CRI $49.00
  • AVG Volume (30 Days)
  • PLSE 230.7K
  • CRI 1.9M
  • Earning Date
  • PLSE 05-06-2025
  • CRI 04-29-2025
  • Dividend Yield
  • PLSE N/A
  • CRI 8.82%
  • EPS Growth
  • PLSE N/A
  • CRI N/A
  • EPS
  • PLSE N/A
  • CRI 5.12
  • Revenue
  • PLSE N/A
  • CRI $2,844,102,000.00
  • Revenue This Year
  • PLSE N/A
  • CRI N/A
  • Revenue Next Year
  • PLSE N/A
  • CRI N/A
  • P/E Ratio
  • PLSE N/A
  • CRI $7.11
  • Revenue Growth
  • PLSE N/A
  • CRI N/A
  • 52 Week Low
  • PLSE $6.60
  • CRI $32.12
  • 52 Week High
  • PLSE $25.00
  • CRI $74.40
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 59.13
  • CRI 42.14
  • Support Level
  • PLSE $16.40
  • CRI $35.16
  • Resistance Level
  • PLSE $16.12
  • CRI $37.95
  • Average True Range (ATR)
  • PLSE 1.25
  • CRI 2.67
  • MACD
  • PLSE 0.35
  • CRI 0.05
  • Stochastic Oscillator
  • PLSE 90.24
  • CRI 42.25

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: